Cancer Prevention Pharmaceuticals

About:

Cancer Prevention Pharmaceuticals develops prevention therapies for people with elevated risk for cancer in the U.S.

Website: http://canprevent.com

Description:

Cancer Prevention Pharmaceuticals, Inc. engages in the development and production of pharmaceutical agents to prevent cancers in people with elevated risk for these diseases in the United States. The company offers difluoro-methyl ornithine for clinical cancer prevention and treatment trials. It also develops diagnostic methods to identify individuals who are at high risk for specific cancers and medicine-related toxicities. In addition, the company develops cancer chemoprevention indications for common cancers along with prevention and therapeutic strategies in certain rare cancers. Cancer Prevention Pharmaceuticals, Inc. was incorporated in 2008 and is based in Tucson, Arizona.

Total Funding Amount:

$16.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tucson, Arizona, United States

Founded Date:

2008-01-01

Contact Email:

cbrannen(AT)canprevent.com

Founders:

Eugene W. Gerner, Frank L. Meyskens

Number of Employees:

1-10

Last Funding Date:

2021-01-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai